Dipropyltryptamine

Dipropyltryptamine

Clinical data
Routes of administration	Ingestion, inhalation, intravenous or intramuscular injection
Identifiers
IUPAC name 3-[2-(dipropylamino)ethyl]indole
CAS Number	61-52-9
PubChem CID	6091
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H24N2
Molar mass	244.38 g/mol
3D model (JSmol)	Interactive image
Melting point	174.5 to 178 °C ( °F)
SMILES CCCN(CCC)CCC1=CNC2=C1C=CC=C2

WikiDoc Resources for Dipropyltryptamine
Articles
Most recent articles on Dipropyltryptamine Most cited articles on Dipropyltryptamine Review articles on Dipropyltryptamine Articles on Dipropyltryptamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dipropyltryptamine Images of Dipropyltryptamine Photos of Dipropyltryptamine Podcasts & MP3s on Dipropyltryptamine Videos on Dipropyltryptamine
Evidence Based Medicine
Cochrane Collaboration on Dipropyltryptamine Bandolier on Dipropyltryptamine TRIP on Dipropyltryptamine
Clinical Trials
Ongoing Trials on Dipropyltryptamine at Clinical Trials.gov Trial results on Dipropyltryptamine Clinical Trials on Dipropyltryptamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dipropyltryptamine NICE Guidance on Dipropyltryptamine NHS PRODIGY Guidance FDA on Dipropyltryptamine CDC on Dipropyltryptamine
Books
Books on Dipropyltryptamine
News
Dipropyltryptamine in the news Be alerted to news on Dipropyltryptamine News trends on Dipropyltryptamine
Commentary
Blogs on Dipropyltryptamine
Definitions
Definitions of Dipropyltryptamine
Patient Resources / Community
Patient resources on Dipropyltryptamine Discussion groups on Dipropyltryptamine Patient Handouts on Dipropyltryptamine Directions to Hospitals Treating Dipropyltryptamine Risk calculators and risk factors for Dipropyltryptamine
Healthcare Provider Resources
Symptoms of Dipropyltryptamine Causes & Risk Factors for Dipropyltryptamine Diagnostic studies for Dipropyltryptamine Treatment of Dipropyltryptamine
Continuing Medical Education (CME)
CME Programs on Dipropyltryptamine
International
Dipropyltryptamine en Espanol Dipropyltryptamine en Francais
Business
Dipropyltryptamine in the Marketplace Patents on Dipropyltryptamine
Experimental / Informatics
List of terms related to Dipropyltryptamine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Dipropyltryptamine (DPT) is a psychedelic drug belonging to the tryptamine family. It is found either as its crystalline hydrochloride salt or as an oily or crystalline base. It has not been found to occur naturally.

Frequent physical effects are nausea, numbness of the tongue or throat, and pupil dilation.

Hallucinogenic Properties

While dipropyltryptamine is chemically similar to dimethyltryptamine, the effects are markedly different.

The most prominent features of the DPT experience are increased significance or intensity of music, colors take on a new intensity or appearance, the body may have a buzz or vibratory feeling, a pleasant sensation of warmth, complete ego loss, apparitions of faces, and visions of bizarre creatures and alien lands.

While seeing other beings under the influence of DPT is not uncommon, the perspective is more as an observer or watcher, as contrasted to the more personal real-feeling entity contact reported with DMT.

Also reported is a loss of ego boundary; for example, the boundary between the self and a table may not be easy to distinguish. Difficulty distinguishing other boundaries is common as well. For example, different colors may be difficult to distinguish. Other sensory input may also become blended. This is distinct from synaesthesia.

A user may also encounter the feeling of experiencing the life of someone else, or having had all possible experiences simultaneously. One may have the experience of seeing the universe from different locations in space and time.

Visuals are often geometric, wavy, and/or spiraled. Other visual distortions and hallucinations tend to be experienced in the peripheral vision. The self or the environment may take on a stylized cartoon-like look or feel. Pleasant flashes of light and sparkles are also common.

Dose

Smoked: When smoked, the effects of DPT have an onset in minutes and a duration of less than one hour. Dosage ranges from 30-100 mg.

Insufflation: Average onset for insufflation of DPT is five to fifteen minutes, and typical dosage ranges from 45-225 mg, but the most popular dose is around 100 mg.

Intramuscular: When injected into the muscle, onset ranges from one minute to fifteen minutes. Typical dosage ranges from 20-110 mg.

Intravenous: When injected intravenously, onset ranges from five to fifteen seconds. Typical dosage ranges from 10-75 mg.

Oral Ingestion: DPT is metabolized by the enzyme monoamine oxidase. While DPT is orally active on its own, the combination with a monoamine oxidase inhibitor (MAOI) can increase the length and intensity of the experience. Oral dosages of 150 - 250 mg are commonly reported, with an onset of 20-60 minutes (depending on stomach content).

Religious use

DPT is used as a religious sacrament by the Temple of the True Inner Light, a New York City offshoot of the Native American Church. The Temple believes DPT and other entheogens are physical manifestations of God.

Notes

Entry in the book TIHKAL about DPT - http://www.erowid.org/library/books_online/tihkal/tihkal09.shtml

External links

• TiHKAL entry
• A DPT Primer by Toad
• Erowid Experience Vault
• Temple of the True Inner Light